Anemia is common following liver transplantation. Because cyclosporine inhibits erythropoietin (Epo) production in experimental models, we investigated whether Epo production was impaired in liver transplant recipients receiving a cyclosporine- or tacrolimus-based immunosuppressive regimen. First, s
Suitable Calcineurin Inhibitor Concentrations for Liver Transplant Recipients in the Chinese Population
β Scribed by Y.B. Chen; S.D. Li; B.L. Ju; X.J. Shi; F. Lu; D.K. Hu; C.H. Yu; J.H. Dong
- Book ID
- 113934927
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 106 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The aim of this work is to report on the results of a singleβcenter, prospective study on the feasibility of calcineurinβinhibitor (CNI)βstaggered immunosuppression by use of extracorporeal photopheresis (ECP) in liver transplant (LT) recipients at risk of renal and neurological complic
Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro